Sjögren's syndrome epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
m (Bot: Removing from Primary care)
 
(12 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Sjögren's syndrome}}
{{Sjögren's syndrome}}
{{CMG}}
{{CMG}} {{AE}} {{F.K}}


==Overview==
==Overview==
The [[incidence]] of Sjögren's syndrome is approximately 4 per 100,000 individuals worldwide. The [[prevalence]] of Sjögren's syndrome is approximately 43 per 100,000 individuals worldwide. The [[mortality rate]] of Sjögren's syndrome is approximately 1.38. Female are more commonly affected by Sjögren's syndrome than male. The majority of Sjögren's syndrome cases are reported in China, Japan, and California.
==Epidemiology and Demographics==
==Epidemiology and Demographics==
===Incidence===
===Incidence===
*The incidence of  Sjögren's syndrome is approximately 4 per 100,000 individuals worldwide.<ref name="pmid11393497">{{cite journal |vauthors=Pillemer SR, Matteson EL, Jacobsson LT, Martens PB, Melton LJ, O'Fallon WM, Fox PC |title=Incidence of physician-diagnosed primary Sjögren syndrome in residents of Olmsted County, Minnesota |journal=Mayo Clin. Proc. |volume=76 |issue=6 |pages=593–9 |date=June 2001 |pmid=11393497 |doi=10.4065/76.6.593 |url=}}</ref>
*The [[incidence]] of  Sjögren's syndrome is approximately 4 per 100,000 individuals worldwide.<ref name="pmid11393497">{{cite journal |vauthors=Pillemer SR, Matteson EL, Jacobsson LT, Martens PB, Melton LJ, O'Fallon WM, Fox PC |title=Incidence of physician-diagnosed primary Sjögren syndrome in residents of Olmsted County, Minnesota |journal=Mayo Clin. Proc. |volume=76 |issue=6 |pages=593–9 |date=June 2001 |pmid=11393497 |doi=10.4065/76.6.593 |url=}}</ref><ref name="pmid23983119">{{cite journal |vauthors=Maldini C, Seror R, Fain O, Dhote R, Amoura Z, De Bandt M, Delassus JL, Falgarone G, Guillevin L, Le Guern V, Lhote F, Meyer O, Ramanoelina J, Sacré K, Uzunhan Y, Leroux JL, Mariette X, Mahr A |title=Epidemiology of primary Sjögren's syndrome in a French multiracial/multiethnic area |journal=Arthritis Care Res (Hoboken) |volume=66 |issue=3 |pages=454–63 |date=March 2014 |pmid=23983119 |doi=10.1002/acr.22115 |url=}}</ref>


===Prevalence===
===Prevalence===
*The prevalence of Sjögren's syndrome is approximately 43 per 100,000 individuals worldwide.
*The [[prevalence]] of Sjögren's syndrome is approximately 43 per 100,000 individuals worldwide.<ref name="pmid24938285">{{cite journal |vauthors=Qin B, Wang J, Yang Z, Yang M, Ma N, Huang F, Zhong R |title=Epidemiology of primary Sjögren's syndrome: a systematic review and meta-analysis |journal=Ann. Rheum. Dis. |volume=74 |issue=11 |pages=1983–9 |date=November 2015 |pmid=24938285 |doi=10.1136/annrheumdis-2014-205375 |url=}}</ref><ref name="pmid9825745">{{cite journal |vauthors=Thomas E, Hay EM, Hajeer A, Silman AJ |title=Sjögren's syndrome: a community-based study of prevalence and impact |journal=Br. J. Rheumatol. |volume=37 |issue=10 |pages=1069–76 |date=October 1998 |pmid=9825745 |doi= |url=}}</ref>
*In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
*The prevalence of [disease/malignancy] is estimated to be [number] cases annually.


===Case-fatality rate/Mortality rate===
===Case-fatality rate/Mortality rate===
*In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
*The [[mortality rate]] of Sjögren's syndrome is approximately 1.38.<ref name="pmid26412810">{{cite journal |vauthors=Singh AG, Singh S, Matteson EL |title=Rate, risk factors and causes of mortality in patients with Sjögren's syndrome: a systematic review and meta-analysis of cohort studies |journal=Rheumatology (Oxford) |volume=55 |issue=3 |pages=450–60 |date=March 2016 |pmid=26412810 |pmc=5009445 |doi=10.1093/rheumatology/kev354 |url=}}</ref>
*The case-fatality rate/mortality rate of [disease name] is approximately [number range].


===Age===
===Age===
*Patients of all age groups may develop [disease name].
*It can occur at any age, but the mean age is usually in the 4th to 5th decade.<ref name="pmid25114590">{{cite journal |vauthors=Patel R, Shahane A |title=The epidemiology of Sjögren's syndrome |journal=Clin Epidemiol |volume=6 |issue= |pages=247–55 |date=2014 |pmid=25114590 |pmc=4122257 |doi=10.2147/CLEP.S47399 |url=}}</ref>
*The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
*[Disease name] commonly affects individuals younger than/older than [number of years] years of age.  
*[Chronic disease name] is usually first diagnosed among [age group].
*[Acute disease name] commonly affects [age group].


===Race===
===Race===
*There is no racial predilection to [disease name].
*There is no racial predilection to Sjögren's syndrome.
*[Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
 
===Gender===
===Gender===
*Female are more commonly affected by Sjögren's syndrome than male. The female to male ratio is approximately 9 to 1.
*Female are more commonly affected by Sjögren's syndrome than male. The female to male ratio is approximately 9 to 1.


===Region===
===Region===
*The majority of Sjögren's syndrome cases are reported in Europe and Asia.
*The majority of Sjögren's syndrome cases are reported in China, Japan, and California.<ref name="pmid8468491">{{cite journal |vauthors=Kang HI, Fei HM, Saito I, Sawada S, Chen SL, Yi D, Chan E, Peebles C, Bugawan TL, Erlich HA |title=Comparison of HLA class II genes in Caucasoid, Chinese, and Japanese patients with primary Sjögren's syndrome |journal=J. Immunol. |volume=150 |issue=8 Pt 1 |pages=3615–23 |date=April 1993 |pmid=8468491 |doi= |url=}}</ref>
 
===Developed Countries===
 
===Developing Countries===


==References==
==References==
{{reflist|2}}
{{reflist|2}}


{{WH}}
[[Category:Medicine]]
{{WS}}
 
[[Category:Immunology]]
[[Category:Immunology]]
[[Category:Rheumatology]]
[[Category:Rheumatology]]
[[Category:Up-To-Date]]

Latest revision as of 00:12, 30 July 2020

Sjögren's syndrome Microchapters

Home

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Sjögren's syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Sjögren's syndrome epidemiology and demographics On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Sjögren's syndrome epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Sjögren's syndrome epidemiology and demographics

CDC on Sjögren's syndrome epidemiology and demographics

Sjögren's syndrome epidemiology and demographics in the news

Blogs on Sjögren's syndrome epidemiology and demographics

Directions to Hospitals Treating Sjögren's syndrome

Risk calculators and risk factors for Sjögren's syndrome epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Farima Kahe M.D. [2]

Overview

The incidence of Sjögren's syndrome is approximately 4 per 100,000 individuals worldwide. The prevalence of Sjögren's syndrome is approximately 43 per 100,000 individuals worldwide. The mortality rate of Sjögren's syndrome is approximately 1.38. Female are more commonly affected by Sjögren's syndrome than male. The majority of Sjögren's syndrome cases are reported in China, Japan, and California.

Epidemiology and Demographics

Incidence

  • The incidence of Sjögren's syndrome is approximately 4 per 100,000 individuals worldwide.[1][2]

Prevalence

  • The prevalence of Sjögren's syndrome is approximately 43 per 100,000 individuals worldwide.[3][4]

Case-fatality rate/Mortality rate

Age

  • It can occur at any age, but the mean age is usually in the 4th to 5th decade.[6]

Race

  • There is no racial predilection to Sjögren's syndrome.

Gender

  • Female are more commonly affected by Sjögren's syndrome than male. The female to male ratio is approximately 9 to 1.

Region

  • The majority of Sjögren's syndrome cases are reported in China, Japan, and California.[7]

References

  1. Pillemer SR, Matteson EL, Jacobsson LT, Martens PB, Melton LJ, O'Fallon WM, Fox PC (June 2001). "Incidence of physician-diagnosed primary Sjögren syndrome in residents of Olmsted County, Minnesota". Mayo Clin. Proc. 76 (6): 593–9. doi:10.4065/76.6.593. PMID 11393497.
  2. Maldini C, Seror R, Fain O, Dhote R, Amoura Z, De Bandt M, Delassus JL, Falgarone G, Guillevin L, Le Guern V, Lhote F, Meyer O, Ramanoelina J, Sacré K, Uzunhan Y, Leroux JL, Mariette X, Mahr A (March 2014). "Epidemiology of primary Sjögren's syndrome in a French multiracial/multiethnic area". Arthritis Care Res (Hoboken). 66 (3): 454–63. doi:10.1002/acr.22115. PMID 23983119.
  3. Qin B, Wang J, Yang Z, Yang M, Ma N, Huang F, Zhong R (November 2015). "Epidemiology of primary Sjögren's syndrome: a systematic review and meta-analysis". Ann. Rheum. Dis. 74 (11): 1983–9. doi:10.1136/annrheumdis-2014-205375. PMID 24938285.
  4. Thomas E, Hay EM, Hajeer A, Silman AJ (October 1998). "Sjögren's syndrome: a community-based study of prevalence and impact". Br. J. Rheumatol. 37 (10): 1069–76. PMID 9825745.
  5. Singh AG, Singh S, Matteson EL (March 2016). "Rate, risk factors and causes of mortality in patients with Sjögren's syndrome: a systematic review and meta-analysis of cohort studies". Rheumatology (Oxford). 55 (3): 450–60. doi:10.1093/rheumatology/kev354. PMC 5009445. PMID 26412810.
  6. Patel R, Shahane A (2014). "The epidemiology of Sjögren's syndrome". Clin Epidemiol. 6: 247–55. doi:10.2147/CLEP.S47399. PMC 4122257. PMID 25114590.
  7. Kang HI, Fei HM, Saito I, Sawada S, Chen SL, Yi D, Chan E, Peebles C, Bugawan TL, Erlich HA (April 1993). "Comparison of HLA class II genes in Caucasoid, Chinese, and Japanese patients with primary Sjögren's syndrome". J. Immunol. 150 (8 Pt 1): 3615–23. PMID 8468491.